The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 11,401–11,500 of 31,469
Modulatory effect of garcinol in streptozotocin-induced diabetic Wistar rats
Madhuri, K., & Naik, P. R. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1336632 · Cited by 31
Miyake, C. N. H., Gualano, B., Dantas, W. S., Pereira, R. T. D. S., Neves, W., Zambelli, V. O., Shinjo, S. K., Pereira, R. M. R., Silva, E. R., de Sá‐Pinto, A. L., et al. (2017) · Arthritis Care & Research · doi:10.1002/acr.23237 · Cited by 32
Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21
Porter, J. W., Rowles, J. L., Fletcher, J. A., Zidon, T. M., Winn, N. C., McCabe, L., Park, Y.-M., Perfield, J. W., Thyfault, J. P., Rector, R. S., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0190 · Cited by 31
Noumegni, S. R., Nansseu, J. R., Moor, V. J. A., Bigna, J. J., Assah, F. K., Guewo‐Fokeng, M., Leumi, S., Katte, J.-C. N., Dehayem, M. Y., Kengne, A. P., et al. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0543-1 · Cited by 31
Rackow, B. W., Brink, H. V., Hammers, L. W., Flannery, C. A., Lujan, M. E., & Burgert, T. S. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2017.09.005 · Cited by 31
Ling, C., Li, Y., Zhang, F., Zhang, S., Zhou, X., & Ji, L. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.001 · Cited by 31
Limitations of insulin resistance assessment in polycystic ovary syndrome
Lewandowski, K. C., Płusajska, J., Horzelski, W., Bieniek, E., & Lewiñski, A. (2018) · Endocrine Connections · doi:10.1530/ec-18-0021 · Cited by 31
Pioltine, M. B., de Melo, M. E., Santos, A. S., Machado, A. D., Fernandes, A. E., Fujiwara, C. T. H., Cercato, C., & Mancini, M. C. (2018) · Journal of Personalized Medicine · doi:10.3390/jpm8010007 · Cited by 30
Davis, S. R., Robinson, P. J., Jane, F., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13830 · Cited by 31
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial
Braun, L. R., Feldpausch, M. N., Czerwonka, N., Weiss, J. J., Branch, K. L., Lee, H., Martínez-Salazar, E. L., Torriani, M., Sponseller, C. A., Grinspoon, S. K., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01446 · Cited by 32
Zhang, Y., & Jia, M. (2019) · Journal of Investigative Surgery · doi:10.1080/08941939.2018.1546352 · Cited by 31
Wilson, J. E., Blizzard, L., Gall, S., et al. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.01.007 · Cited by 31
Timing Modulates the Effect of Sleep Loss on Glucose Homeostasis
Wilms, B., Chamorro, R., Hallschmid, M., Trost, D., Forck, N., Schultes, B., Mölle, M., Sayk, F., Lehnert, H., & Schmid, S. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02636 · Cited by 33
Aranaz, P., Navarro‐Herrera, D., Romo‐Hualde, A., Zabala, M., Lópeź‐Yoldi, M., González-Ferrero, C., Gil, A. G., Martínez, J. A., Vizmanos, J. L., Milagro, F. I., et al. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.05.054 · Cited by 31
Pott, H., Nascimento, C. M. C., Costa-Guarisco, L. P., Gomes, G. A. D. O., Gramani‐Say, K., Orlandi, F. D. S., Gratão, A. C. M., dos Santos‐Orlandi, A. A., Pavarini, S. C. I., Vasilceac, F. A., et al. (2020) · Nutrients · doi:10.3390/nu12030748 · Cited by 31
Nath, P., Panigrahi, M. K., Sahu, M. K., Narayan, J., Sahoo, R. K., Patra, A. A., Jena, S., Patnaik, A. K., Jena, A., & Singh, S. P. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2019.00012 · Cited by 33
Giallauria, F., Vitelli, A., Maresca, L., de Magistris, M. S., Chiodini, P., Mattiello, A., Gentile, M., Mancini, M. E., Grieco, A., Russo, A., et al. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1259-8 · Cited by 31
Soyama, A., Nishikawa, T., Ishizuka, T., Itô, H., Saito, J., Kazuo, Y. A. G. I., & Saitō, Y. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.229 · Cited by 31
Increased visceral fat accumulation further aggravates the risks of insulin resistance in gout
Takahashi, S., Moriwaki, Y., Tsutsumi, Z., et al. (2001) · Metabolism · doi:10.1053/meta.2001.21688 · Cited by 31
Farrer, M., Fulcher, G. R., Albers, C., Neil, H. A. W., Adams, P. C., & Alberti, K. G. M. M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90099-3 · Cited by 31
Sheu, W. H., Lee, W., Lin, L., Chang, R., & Chen, Y.-T. (2001) · Metabolism · doi:10.1053/meta.2001.27192 · Cited by 31
Insulin sensitivity predicts glycemia after a protein load
Brand-Miller, J. C., Colagiuri, S., & Gan, S. T. (2000) · Metabolism · doi:10.1016/s0026-0495(00)90488-8 · Cited by 31
Liu, I.-M., Tzeng, T., & Liou, S. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep004 · Cited by 31
High plasma leptin predicts an increase in subcutaneous adiposity in children and adults
Kettaneh, A., Heude, B., Romon, M., Oppert, J., Borys, J. M., Balkau, B., Ducimetière, P., & Charles, M.-A. A. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602579 · Cited by 31
de Luis, D. A., Aller, R., Izaola, O., Sagrado, M. G., & Conde, R. (2008) · Annals of Nutrition and Metabolism · doi:10.1159/000144047 · Cited by 31
Immunological mechanisms associated with long‐term remission of human type 1 diabetes
Karges, B., Durinovic‐Belló, I., Heinze, E., Debatin, K., Boehm, B. O., & Karges, W. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.600 · Cited by 31
Solá, E., Vayá, A., España, F., Castelló, R., Ramón, L., Hernández‐Mijares, A., Vicente, V., & Estellés, A. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.10.016 · Cited by 31
Earlier triple therapy with pioglitazone in patients with type 2 diabetes
Charpentier, G., Halimi, S., & on behalf of the F‐PIO‐100 Study Investigators (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01055.x · Cited by 31
Li, H., Groop, L., Nilsson, A., Weng, J., & Tuomilehto, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020506 · Cited by 31
Bray, I., Gunnell, D., Holly, J. M. P., Middleton, N., Smith, G. D., & Martin, R. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1722 · Cited by 31
Finnie, A. K., Buchholz, A. C., & Ginis, K. A. M. (2008) · Spinal Cord · doi:10.1038/sc.2008.21 · Cited by 31
Ertunç, D., Tok, E. C., Aktas, A., Erdal, M. E., & Dilek, S. (2005) · Human Reproduction · doi:10.1093/humrep/deh747 · Cited by 31
Pontiroli, A. E., Pizzocri, P., Paroni, R. C., & Folli, F. B. (2006) · Diabetes Care · doi:10.2337/dc06-1417 · Cited by 31
Lower body subcutaneous fat accumulation and diabetes mellitus risk
Livingston, E. H. (2006) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2006.02.009 · Cited by 31
Kumar, A., Tewari, P., Sahoo, S., & Srivastava, A. K. (2005) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02867394 · Cited by 31
Shiwaku, K., Hashimoto, M., Kitajima, K., Nogi, A., Anuurad, E., Enkhmaa, B., Kim, J.-M., Kim, I., Lee, S., Oyunsuren, T., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300483-jlr200 · Cited by 31
Hermsdorff, H. H. M., Barbosa, K. B., Volp, A. C. P., Puchau, B., Bressan, J., Zulet, M. Á., & Martínez, J. A. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312472420 · Cited by 31
Metabolic Effects of Liposuction — Yes or No?
Esposito, K., Giugliano, G., & Giugliano, D. (2004) · New England Journal of Medicine · doi:10.1056/nejm200409233511320 · Cited by 31
Arterial wall thickness is associated with insulin resistance in type 2 diabetic patients.
Fujiwara, S., Emoto, M., Komatsu, M., Motoyama, K., Morioka, T., Koyama, H., Shoji, T., Inaba, M., & Nishizawà, Y. (2003) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.10.246 · Cited by 38
The Dehydroepiandrosterone And WellNess (DAWN) study: Research design and methods
von Mühlen, D. G., Laughlin, G. A., Kritz‐Silverstein, D. C., & Barrett-Connor, E. L. (2006) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.04.009 · Cited by 32
Clinical utility and approaches for estimating insulin sensitivity in pregnancy
Catalano, P. M., & Kirwan, J. P. (2002) · Seminars in Perinatology · doi:10.1053/sper.2002.33977 · Cited by 30
Ho, R. C., Davy, K. P., Hickey, M. S., & Melby, C. L. (2005) · Cytokine · doi:10.1016/j.cyto.2004.10.015 · Cited by 33
Clustering of insulin resistance, total and central abdominal fat: same genes or same environment?
Samaras, K., Nguyen, T. V., Jenkins, A. B., Eisman, J. A., Howard, G., Kelly, P. J., & Campbell, L. V. (1999) · Twin Research · doi:10.1375/136905299320565898 · Cited by 31
Birkeland, K. I., Kilhovd, B. K., Thorsby, P. M., Torjesen, P. A., Ganss, R., Vaaler, S., & Hanssen, K. F. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00838.x · Cited by 31
Is insulin resistance or diabetes mellitus associated with stroke?
Adachi, H., Hirai, Y., Tsuruta, M., Fujiura, Y., & Imaizuml, T. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00236-9 · Cited by 31
The impact of ethnicity on glucose homeostasis after gestational diabetes mellitus
Ignell, C., Shaat, N., Ekelund, M., & Berntorp, K. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0484-8 · Cited by 30
Richard, A. J., Fuller, S., Fedorcenco, V., Beyl, R., Burris, T. P., Mynatt, R., Ribnicky, D. M., & Stephens, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098897 · Cited by 30
Carr, L. J., Bartee, R. T., Dorozynski, C. M., Broomfield, J. F., Smith, M. L., & Smith, D. T. (2009) · Journal of Physical Activity and Health · doi:10.1123/jpah.6.4.444 · Cited by 28
Kakinami, L., Knäuper, B., & Brunet, J. (2020) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2019-213419 · Cited by 32
Real, J. T., Martínez-Hervás, S., Tormos, M. C., Domenech, E., Pallardó, F. V., Sáez-Tormo, G., Redon, J., Carmena, R., Chaves, F. J., Ascaso, J. F., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2009.07.026 · Cited by 30
Takeshita, Y., Takamura, T., Kita, Y., Otoda, T., Kato, K., Wakakuri, H., Yamada, M., Misu, H., Matsushima, Y., Kaneko, S., et al. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12269 · Cited by 35
Phillips, M. L., Boase, S., Wahlroos, S., Dugar, M., Kow, L., Stahl, J., Slavotinek, J. P., Valentine, R., Toouli, J., & Thompson, C. H. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00793.x · Cited by 34
Ali, S. B., Jemaa, R., Ftouhi, B., Kallel, A., Feki, M., Sliméne, H., & Kaabachi, N. (2011) · Cytokine · doi:10.1016/j.cyto.2011.06.026 · Cited by 30
Is there association between vitamin D levels, apelin 36, and visfatin in PCOS?
Çağlayan, E. K., Üstün, Y. E., Sarı, N., Göçmen, A. Y., Seçkin, L., Kara, M., Mahmutoglu, A. M., & Polat, M. F. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1124260 · Cited by 30
Chen, P., Baylín, A., Lee, J. M., Dunietz, G. L., Cantoral, A., Téllez‐Rojo, M. M., Peterson, K. E., & Jansen, E. C. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.10.012 · Cited by 30
Scully, K. J., Jay, L. T., Freedman, S. D., Sawicki, G. S., Uluer, A., Finkelstein, J. S., & Putman, M. S. (2022) · Nutrients · doi:10.3390/nu14020310 · Cited by 30
Jung, W.-S., Kim, Y.-Y., Kim, J.-W., & Park, H.-Y. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2304134 · Cited by 30
Roh, E., Hwang, S. Y., Song, E., Park, M., Yoo, H. J., Baik, S. H., Kim, M., Won, C. W., & Choi, K. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-19706-3 · Cited by 32
Mihuţa, M. S., Paul, C., Borlea, A., Roi, C. M., Pescari, D., Velea-Barta, O.-A., Mozos, I. M., & Stoian, D. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1253584 · Cited by 34
von Schwartzenberg, R. J., Arreola, E. V., Sandforth, A., Hanson, R. L., & Birkenfeld, A. L. (2024) · Diabetologia · doi:10.1007/s00125-024-06178-5 · Cited by 31
Schwenger, K. J. P., Ghorbani, Y., Bharatselvam, S., Chen, L., Chomiak, K. M., Tyler, A. C., Eddingsaas, N. C., Fischer, S. E., Jackson, T. D., Okrainec, A., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176153 · Cited by 36
Yang, H. J., Lim, J., Park, K., Kang, S., Kim, D. S., & Park, S. (2015) · Nutrition · doi:10.1016/j.nut.2015.07.012 · Cited by 30
Tsuboi, A., Ito, C., Fujikawa, R., Yamamoto, H., & Kihara, Y. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.3596 · Cited by 30
Cambuli, V. M., Galdiero, M., Mastinu, M., Pigliaru, F., Rs, A., Ciresi, A., Pivonello, R., Amato, M. C., Giordano, C. S. D. S., Mariotti, S., et al. (2012) · PubMed · doi:10.3275/7685 · Cited by 30
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1
Petta, S., Marco, V. D., Stefano, R. D., et al. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01439.x · Cited by 30
Aboouf, M. A., Hamdy, N. Μ., Amin, A. I., & EL-Mesallamy, H. O. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.016 · Cited by 30
Prevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors.
Bilecik, N. A., Tuna, S., Samancı, N., Balcı, N., & Akbas, H. S. (2014) · Europe PMC (PubMed Central) · Cited by 30
Floh, A. A., Manlhiot, C., Redington, A. N., McCrindle, B. W., Clarizia, N. A., Caldarone, C. A., & Schwartz, S. M. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.06.028 · Cited by 30
Effects of auricular stimulation on obese women: A randomized, controlled clinical trial
Lien, C.-Y., Liao, L.-L., Chou, P., & Hsu, C.-H. (2012) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2011.12.002 · Cited by 31
Calisto, K. L., Carvalho, B. D. M., Ropelle, E. R., Mittestainer, F. C., Camacho, A. C. A., Guadagnini, D., Carvalheira, J. B. C., & Saad, M. J. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014232 · Cited by 31
RetractedPlasma endothelin-1 and cardiovascular risk among young and healthy adults
Bossard, M., Pumpol, K., van der Lely, S., Aeschbacher, S., Schoen, T., Krisai, P., Lam, T., Todd, J., Estis, J., Risch, M., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.061 · Cited by 33
Nascimento, H., Costa, E. M., Rocha, S., Lucena, C., Rocha‐Pereira, P., Rêgo, C., Mansilha, H. F., Quintanilha, A. T., Aires, L., Mota, J. A. P. S., et al. (2014) · Pediatric Research · doi:10.1038/pr.2014.73 · Cited by 30
Danilla, S., Longton, C., Valenzuela, K., Cavada, G., B, H. N., Tabilo, C., Erazo, C., Benítez, S., Sepulveda, S., Rosales, R. S., et al. (2013) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2013.07.001 · Cited by 29
Radhakishun, N. N. E., Blokhuis, C., van Vliet, M., et al. (2014) · European Journal of Pediatrics · doi:10.1007/s00431-014-2276-8 · Cited by 30
Loko, M., Bani‐Sadr, F., Valantin, M., et al. (2012) · Antiviral Therapy · doi:10.3851/imp2419 · Cited by 30
IGF2 Methylation Is Associated with Lipid Profile in Obese Children
Deodati, A., Inzaghi, E., Liguori, A., Puglianiello, A., Germani, D., Brufani, C., Fintini, D., Cappa, M., Barbetti, F., & Cianfarani, S. (2013) · Hormone Research in Paediatrics · doi:10.1159/000351707 · Cited by 31
Gijón‐Conde, T., Graciani, A., Guallar‐Castillón, P., Aguilera, M. T., Rodríguez‐Artalejo, F., & Banegas, J. R. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.08.015 · Cited by 31
Chung, G. E., Kim, D., Kwark, M. S., Kim, W. K., Yim, J. Y., Kim, Y. J., & Yoon, J. (2015) · Medicine · doi:10.1097/md.0000000000000573 · Cited by 32
Siljander, H., Hermann, R., Hekkala, A., Lähde, J., Tanner, L. M., Keskinen, P., Ilonen, J., Simell, O., Veijola, R., & Knip, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0206 · Cited by 30
Riddle, E., Campbell, M. S., Lang, B. Y., Bierer, R., Wang, Y., Bagley, H. N., & Joss-Moore, L. (2014) · Journal of Obesity · doi:10.1155/2014/829862 · Cited by 32
Cui, Y., Liu, H., Liu, Y., Wu, Y.-M., & Liang, J. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e328360c6b9 · Cited by 29
Mizuno, Y., Harada, E., Katoh, D., Kashiwagi, Y., Morikawa, Y., Nakagawa, H., Yoshimura, M., Saito, Y., & Yasue, H. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0239 · Cited by 30
PNPLA 3 rs738409 I748M is associated with steatohepatitis in 434 non‐obese subjects with hepatitis C
Petta, S., Vanni, E., Bugianesi, E., Rosso, C., Cabibi, D., Cammà, C., Marco, V. D., Eslam, M., Grimaudo, S., Macaluso, F. S., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13169 · Cited by 30
Metabolic syndrome: comparison of diagnosis criteria
Cavali, M. D. L. R., Escrivão, M. A. M. S., Brasileiro, R. S., & Carrazedo, J. E. A. D. A. (2010) · Jornal de Pediatria · doi:10.2223/jped.2006 · Cited by 30
Russo, G. I., Cimino, S., Fragalà, E., et al. (2014) · World Journal of Urology · doi:10.1007/s00345-014-1392-4 · Cited by 30
Ong, K. L., Wu, B. J., Cheung, B. M. Y., Barter, P. J., & Rye, K. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.094 · Cited by 30
Asthma and insulin resistance in obese children and adolescents
Jiménez, J. S., Herrero, F.-J., Garrido, J. M. M., Antonio, J. R., Mayor, S. P., Boira, M. P., Comas, A. R., & Martínez, A. B. (2014) · Pediatric Allergy and Immunology · doi:10.1111/pai.12294 · Cited by 30
Obstructive Sleep Apnea and Metabolic Syndrome in Spanish Population
Barreiro, B., Garcia, L., Lozano, L., Almagro, P., Quintana, S., Alsina, M., & Heredia, J. L. (2013) · The Open Respiratory Medicine Journal · doi:10.2174/1874306401307010071 · Cited by 33
Sakurai, M., Miura, K., Takamura, T., Ishizaki, M., Morikawa, Y., Nakamura, K., Yoshita, K., Kido, T., Naruse, Y., Kaneko, S., et al. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02773.x · Cited by 33
Adamsson, V., Reumark, A., Marklund, M., Larsson, A. O., & Risérus, U. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.04.009 · Cited by 30
Bruder-Nascimento, T. B., Baptista, R. D. F. F., Pereira, P. C., de Campos, D. H. S., Leopoldo, A. S., Lima‐Leopoldo, A. P., de Oliveira-Junior, S. A., Padovani, C. R., Cicogna, A. C., & Cordellini, S. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011005000063 · Cited by 30
PAI‐1 Gene 4G/5G Polymorphism and Risk of Type 2 Diabetes in a Population‐based Sample
Meigs, J. B., Dupuis, J., Liu, C., O’Donnell, C. J., Fox, C. S., Kathiresan, S., Gabriel, S., Larson, M. G., Yang, Q., Herbert, A. G., et al. (2006) · Obesity · doi:10.1038/oby.2006.85 · Cited by 30
Increased Serum Apolipoprotein B48 Concentration in Patients with Metabolic Syndrome
Kinoshita, M., Ohnishi, H., Maeda, T., Yoshimura, N., Takeoka, Y., Yasuda, D., Kusano, J., Mashimo, Y., Saito, S., Shimamoto, K., et al. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.no604 · Cited by 30
Derosa, G., Romano, D., D’Angelo, A., & Maffioli, P. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.11.018 · Cited by 30
Lucero, D., Zago, V., López, G. H., Cacciagiú, L. D., Lopez, G. I., Wikinski, R., Nakajima, K., & Schreier, L. E. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.12.013 · Cited by 29
Maayan, L. A., & Vakhrusheva, J. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1097 · Cited by 30
Fujita, Y., Kozawa, J., Iwahashi, H., Yoneda, S., Uno, S., Yoshikawa, A., Okita, K., Eguchi, H., Nagano, H., Imagawa, A., et al. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej14-0456 · Cited by 30
Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans
Thrush, A. B., Heigenhauser, G. J., Mullen, K. L., Wright, D. C., & Dyck, D. J. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00909.2007 · Cited by 30
Hermans, M. P., Pepersack, T., Godeaux, L. H., Beyer, I., & Turc, A. (2005) · The Journals of Gerontology Series A · doi:10.1093/gerona/60.2.241 · Cited by 30
Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome
González, F., Kirwan, J. P., Rote, N. S., & Minium, J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2012 · Cited by 30
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
